Understanding the prospective toxicity of candidate molecules is of the utmost significance during drug advancement. However, current cell culture and animal models stop working to recapitulate human physiology and offer misleading, inaccurate outcomes during toxicology testing. Organ-on-a-chip innovation makes and uses exceptional results drug discovery more effective by simulating the responses of human cells in the body.
View this webinar from Emulate to learn how a liver chip compares to hepatic spheroids and a liver animal design during drug toxicity testing.